Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

14.28
Delayed Data
As of Aug 28
 0.00 / 0.00%
Today’s Change
5.34
Today|||52-Week Range
19.43
+134.10%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues16.4M35.5M59.9M85.5M
 
 
 
 
 
Depreciation And Amortization4.6M4.6M4.6M5.5M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses85.0M103.9M126.8M134.5M
 
 
 
 
 
Research And Development69.2M87.1M107.0M111.8M
 
 
 
 
 
Total Operating Expenses89.6M108.5M131.4M140.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-73.3M-73.0M-71.5M-54.5M
 
 
 
 
 
Extraordinary Credit0.00197.0K2.0K0.00
 
 
 
Extraordinary Charge-173.0K0.000.000.00
 
 
Interest Expense On Debt0.000.00--5.4M
 
 
Other Expenses45.0K1.0K121.0K-916.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-73.3M-72.8M-71.4M-60.7M
 
 
 
 
 
Net Income-73.3M-72.8M-71.4M-60.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS76.8M84.1M85.5M86.0M
 
 
 
 
 
Shares To Calculate EPS Diluted76.8M84.1M85.5M86.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.95-$0.87-$0.83-$0.71
 
 
 
 
 
EPS Diluted-$0.95-$0.87-$0.83-$0.71